TransMedics Group Future Growth
Future criteria checks 5/6
TransMedics Group is forecast to grow earnings and revenue by 33.4% and 19.1% per annum respectively. EPS is expected to grow by 30.9% per annum. Return on equity is forecast to be 20.9% in 3 years.
Key information
33.4%
Earnings growth rate
30.9%
EPS growth rate
| Medical Equipment earnings growth | 17.0% |
| Revenue growth rate | 19.1% |
| Future return on equity | 20.9% |
| Analyst coverage | Good |
| Last updated | 21 Nov 2024 |
Recent future growth updates
Recent updates
These 4 Measures Indicate That TransMedics Group (NASDAQ:TMDX) Is Using Debt Reasonably Well
Nov 20
TransMedics: Long-Term Thesis Hasn't Changed At All
Nov 19TransMedics: Overreaction To Temporary Headwinds (Rating Upgrade)
Nov 12What You Can Learn From TransMedics Group, Inc.'s (NASDAQ:TMDX) P/S After Its 44% Share Price Crash
Oct 30TransMedics: Mistakes Have Been Made, Here's My Updated Outlook
Oct 29TransMedics' Organ Care: Critical Innovation With Lofty Expectations
Oct 23TransMedics Group: This Could Be One Of The Biggest Moats In A Decade
Oct 16Returns Are Gaining Momentum At TransMedics Group (NASDAQ:TMDX)
Sep 18TransMedics: Take Profits While The Valuation Is Sky High
Sep 18TransMedics: Wide Moat Player At A Lower Valuation Than Peers
Sep 10TransMedics Group, Inc.'s (NASDAQ:TMDX) P/S Is Still On The Mark Following 25% Share Price Bounce
Aug 28TransMedics: Heart And Lungs Will Drive The Next Leg Higher
Aug 19Analysts Just Made A Meaningful Upgrade To Their TransMedics Group, Inc. (NASDAQ:TMDX) Forecasts
Aug 06TransMedics Group: Providing Long-Term Detailed Forecast And Upgrading To Buy
Aug 04TransMedics Group, Inc. Just Recorded A 66% EPS Beat: Here's What Analysts Are Forecasting Next
Aug 02TransMedics Group Stock: Too Far, Too Fast
Jul 08TransMedics: NOP, Logistics And Transport Are Key Growth Drivers But Stock Is Pricey
Jun 17TransMedics Group (NASDAQ:TMDX) Might Have The Makings Of A Multi-Bagger
Jun 10TransMedics: Transportation Supporting Growth
May 21TransMedics Group: Looking At The Road Ahead After An Exceptional Q1 (Rating Downgrade)
May 06TransMedics Group, Inc. (NASDAQ:TMDX) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable
Apr 24TransMedics Group: Founder Led Company With Solid Potential
Apr 19Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?
Apr 11TransMedics Group: Emerging Medical Device Market Leader With A Long Growth Runway
Mar 19TransMedics Group: Huge Opportunity In Organ Transplants
Mar 12TransMedics: A Very Expensive Growth Stock
Feb 07With TransMedics Group, Inc. (NASDAQ:TMDX) It Looks Like You'll Get What You Pay For
Jan 23Calculating The Fair Value Of TransMedics Group, Inc. (NASDAQ:TMDX)
Jan 02Does TransMedics Group (NASDAQ:TMDX) Have A Healthy Balance Sheet?
Nov 05This Just In: Analysts Are Boosting Their TransMedics Group, Inc. (NASDAQ:TMDX) Outlook for This Year
Aug 06TransMedics Group (NASDAQ:TMDX) Has Debt But No Earnings; Should You Worry?
Aug 02TransMedics Group, Inc. (NASDAQ:TMDX) Not Lagging Industry On Growth Or Pricing
Jun 29Brokers Are Upgrading Their Views On TransMedics Group, Inc. (NASDAQ:TMDX) With These New Forecasts
May 06Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?
Apr 27Estimating The Intrinsic Value Of TransMedics Group, Inc. (NASDAQ:TMDX)
Apr 09Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 653 | 99 | 106 | 129 | 7 |
| 12/31/2025 | 545 | 54 | 49 | 79 | 10 |
| 12/31/2024 | 432 | 34 | -48 | 61 | 10 |
| 9/30/2024 | 401 | 33 | -121 | 37 | N/A |
| 6/30/2024 | 359 | 3 | -221 | 24 | N/A |
| 3/31/2024 | 297 | -10 | -230 | -8 | N/A |
| 12/31/2023 | 242 | -25 | -192 | -13 | N/A |
| 9/30/2023 | 192 | -36 | -165 | -25 | N/A |
| 6/30/2023 | 151 | -18 | -41 | -33 | N/A |
| 3/31/2023 | 119 | -28 | -47 | -36 | N/A |
| 12/31/2022 | 93 | -36 | -58 | -46 | N/A |
| 9/30/2022 | 72 | -42 | -61 | -48 | N/A |
| 6/30/2022 | 51 | -48 | -53 | -43 | N/A |
| 3/31/2022 | 39 | -47 | -45 | -40 | N/A |
| 12/31/2021 | 30 | -44 | -32 | -29 | N/A |
| 9/30/2021 | 28 | -38 | -30 | -29 | N/A |
| 6/30/2021 | 30 | -30 | -27 | -26 | N/A |
| 3/31/2021 | 25 | -28 | -30 | -29 | N/A |
| 12/31/2020 | 26 | -29 | -31 | -30 | N/A |
| 9/30/2020 | 24 | -32 | -31 | -30 | N/A |
| 6/30/2020 | 24 | -35 | -30 | -30 | N/A |
| 3/31/2020 | 26 | -36 | -34 | -33 | N/A |
| 12/28/2019 | 24 | -34 | -32 | -32 | N/A |
| 9/28/2019 | 21 | -32 | -31 | -31 | N/A |
| 6/29/2019 | 18 | -29 | -32 | -32 | N/A |
| 3/30/2019 | 15 | -26 | -27 | -27 | N/A |
| 12/29/2018 | 13 | -24 | -26 | -26 | N/A |
| 9/29/2018 | 12 | -21 | N/A | -25 | N/A |
| 6/30/2018 | 9 | -20 | N/A | -24 | N/A |
| 3/31/2018 | 8 | -20 | N/A | -23 | N/A |
| 12/30/2017 | 8 | -21 | N/A | -23 | N/A |
| 12/31/2016 | 6 | -24 | N/A | -24 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TMDX's forecast earnings growth (33.4% per year) is above the savings rate (2.6%).
Earnings vs Market: TMDX's earnings (33.4% per year) are forecast to grow faster than the US market (15.4% per year).
High Growth Earnings: TMDX's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: TMDX's revenue (19.1% per year) is forecast to grow faster than the US market (9% per year).
High Growth Revenue: TMDX's revenue (19.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: TMDX's Return on Equity is forecast to be high in 3 years time (20.9%)